new COX-2 inhibitor called Bextra (valdecoxib)
You'll see a new COX-2 inhibitor called Bextra (valdecoxib).
It'll be co-marketed by Pharmacia and Pfizer...the same companies that market Celebrex (celecoxib).
Bextra is approved for osteoarthritis...rheumatoid arthritis...and dysmenorrhea. It's NOT approved yet for acute pain...but it probably will be after the company submits additional studies to the FDA.